WANG Zi-Wei,CUI Hong. Neonatal cerebral infarction associated with low levels of protein C and protein S activity: a case report[J]. CJCP, 2012, 14(10): 798-799.
［4］Guther G, Junker R, Strater R, Schobess R, Kurnik K, Heller C, et al. Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors［J］. Stroke, 2000, 31(10): 2437-2441.
［5］Simchen MJ, Goldstein G, Lubetsky A, Strauss T, Schiff E, Kenet G. Factor V Leiden and antiphospholipid antibodies in either mothers or infants increase the risk for perinatal arterial ischemic stroke［J］. Stroke, 2009, 40(1): 65-70.
［6］Kirton A, deVeber G. Advances in perinatal ischemic stroke［J］. Pediatr Neurol, 2009, 40(3): 205-214.
［7］Lee J, Croen LA, Backstrand KH, Yoshida CK, Henning LH, Lindan C, et al. Maternal and infant characteristics associated with perinatal arterial stroke in the infant［J］. JAMA, 2005, 293(6): 723-729.
［8］Grabowski EF, Buonanno FS, Krishnamoorthy K. Prothrombotic risk factors in the evaluation and management of perinatal stroke［J］. Semin Perinatol, 2007, 31(4): 243-249.
［9］Benders MJ, Groenendaal F, Uiterwaal CS, de Vries LS. Perinatal arterial stroke in the preterm infant［J］. Semin Perinatol, 2008, 32(5): 344-349.
［10］Kurnik K, Kosch A, Strater R, Schobess R, Heller C, Nowak-Gottl U. Recurrent thromboembolismin infants and children suffering from symptomatic neonatal arterial stroke: a prospective follow-up study［J］. Stroke, 2003, 34(12): 2887-2892.
［11］Koppelman SJ, Van′t Veer C, Sixma JJ, Bouma BN. Synergistic inhibition of the intrinsic factor X activation by protein S and C4b-binding protein［J］. Blood, 1995, 86(7): 2653-2660.
